Trials / Completed
CompletedNCT03979898
Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With CP
Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With Cerebral Palsy (CP)
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- R-Bio · Industry
- Sex
- All
- Age
- 36 Months – 12 Years
- Healthy volunteers
- Not accepted
Summary
Safety and Effectiveness of Autologous Adipose Tissue Derived mesenchymal Stem Cell Implantation in Patients with CP
Detailed description
The purpose of this study is to investigate the efficacy and safety of autologous transplantation of Adipose Tissue derived Mesenchymal stem cells (MSCs) in patient with Cerebral Palsy(CP)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ASTROSTEM | Intravenous injection of Autologous Adipose derived mesenchymal stem cells. Dose : 15kg below : 0.5x10\^7cells/5mL 15kg \~ 25kg : 1x10\^8cells/10mL 25kg over : 1.5x10\^8cells/15mL |
Timeline
- Start date
- 2017-06-15
- Primary completion
- 2019-04-23
- Completion
- 2019-05-13
- First posted
- 2019-06-07
- Last updated
- 2019-06-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03979898. Inclusion in this directory is not an endorsement.